Literature DB >> 31033011

Sample size considerations for stratified cluster randomization design with binary outcomes and varying cluster size.

Xiaohan Xu1,2, Hong Zhu1, Chul Ahn1.   

Abstract

Stratified cluster randomization trials (CRTs) have been frequently employed in clinical and healthcare research. Comparing with simple randomized CRTs, stratified CRTs reduce the imbalance of baseline prognostic factors among different intervention groups. Due to the popularity, there has been a growing interest in methodological development on sample size estimation and power analysis for stratified CRTs; however, existing work mostly assumes equal cluster size within each stratum and uses multilevel models. Clusters are often naturally formed with random sizes in CRTs. With varying cluster size, commonly used ad hoc approaches ignore the variability in cluster size, which may underestimate (overestimate) the required number of clusters for each group per stratum and lead to underpowered (overpowered) clinical trials. We propose closed-form sample size formulas for estimating the required total number of subjects and for estimating the number of clusters for each group per stratum, based on Cochran-Mantel-Haenszel statistic for stratified cluster randomization design with binary outcomes, accounting for both clustering and varying cluster size. We investigate the impact of various design parameters on the relative change in the required number of clusters for each group per stratum due to varying cluster size. Simulation studies are conducted to evaluate the finite-sample performance of the proposed sample size method. A real application example of a pragmatic stratified CRT of a triad of chronic kidney disease, diabetes, and hypertension is presented for illustration.
© 2019 John Wiley & Sons, Ltd.

Entities:  

Keywords:  binary outcomes; cluster randomization design; sample size; stratification; varying cluster size

Year:  2019        PMID: 31033011      PMCID: PMC6649663          DOI: 10.1002/sim.8175

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  18 in total

1.  GEE analysis of negatively correlated binary responses: a caution.

Authors:  J A Hanley; A Negassa; M D Edwardes
Journal:  Stat Med       Date:  2000-03-15       Impact factor: 2.373

2.  Bayesian methods of analysis for cluster randomized trials with binary outcome data.

Authors:  R M Turner; R Z Omar; S G Thompson
Journal:  Stat Med       Date:  2001-02-15       Impact factor: 2.373

3.  Estimating intraclass correlation for binary data.

Authors:  M S Ridout; C G Demétrio; D Firth
Journal:  Biometrics       Date:  1999-03       Impact factor: 2.571

4.  Sample size requirements for estimating intraclass correlations with desired precision.

Authors:  Douglas G Bonett
Journal:  Stat Med       Date:  2002-05-15       Impact factor: 2.373

5.  Confidence interval estimation of the intraclass correlation coefficient for binary outcome data.

Authors:  Guangyong Zou; Allan Donner
Journal:  Biometrics       Date:  2004-09       Impact factor: 2.571

6.  Comparing completely and stratified randomized designs in cluster randomized trials when the stratifying factor is cluster size: a simulation study.

Authors:  J D Lewsey
Journal:  Stat Med       Date:  2004-03-30       Impact factor: 2.373

7.  Cluster randomized controlled trials in primary care: an introduction.

Authors:  Andrew W Murphy; Adrian Esterman; Louis S Pilotto
Journal:  Eur J Gen Pract       Date:  2006       Impact factor: 1.904

8.  Cluster randomized controlled trials.

Authors:  Suezann Puffer; David J Torgerson; Judith Watson
Journal:  J Eval Clin Pract       Date:  2005-10       Impact factor: 2.431

9.  Sample size requirements for stratified cluster randomization designs.

Authors:  A Donner
Journal:  Stat Med       Date:  1992-04       Impact factor: 2.373

Review 10.  Reporting of analyses from randomized controlled trials with multiple arms: a systematic review.

Authors:  Gabriel Baron; Elodie Perrodeau; Isabelle Boutron; Philippe Ravaud
Journal:  BMC Med       Date:  2013-03-27       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.